- Home
- RCUS vs NNE Comparison
RCUS vs NNE Comparison
Compare RCUS & NNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- NNE
- Stock Information
- Founded
- RCUS 2015
- NNE 2022
- Country
- RCUS United States
- NNE United States
- Employees
- RCUS N/A
- NNE N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- NNE
- Sector
- RCUS Health Care
- NNE
- Exchange
- RCUS Nasdaq
- NNE NYSE
- Market Cap
- RCUS 727.1M
- NNE 760.7M
- IPO Year
- RCUS 2018
- NNE 2024
- Fundamental
- Price
- RCUS $7.88
- NNE $19.86
- Analyst Decision
- RCUS Strong Buy
- NNE Strong Buy
- Analyst Count
- RCUS 10
- NNE 2
- Target Price
- RCUS $29.50
- NNE $58.00
- AVG Volume (30 Days)
- RCUS 1.2M
- NNE 1.8M
- Earning Date
- RCUS 05-07-2025
- NNE 02-13-2025
- Dividend Yield
- RCUS N/A
- NNE N/A
- EPS Growth
- RCUS N/A
- NNE N/A
- EPS
- RCUS N/A
- NNE N/A
- Revenue
- RCUS $258,000,000.00
- NNE N/A
- Revenue This Year
- RCUS N/A
- NNE N/A
- Revenue Next Year
- RCUS $25.77
- NNE N/A
- P/E Ratio
- RCUS N/A
- NNE N/A
- Revenue Growth
- RCUS 120.51
- NNE N/A
- 52 Week Low
- RCUS $6.50
- NNE $3.25
- 52 Week High
- RCUS $18.98
- NNE $48.05
- Technical
- Relative Strength Index (RSI)
- RCUS 44.26
- NNE N/A
- Support Level
- RCUS $6.75
- NNE N/A
- Resistance Level
- RCUS $8.36
- NNE N/A
- Average True Range (ATR)
- RCUS 0.60
- NNE 0.00
- MACD
- RCUS 0.16
- NNE 0.00
- Stochastic Oscillator
- RCUS 74.19
- NNE 0.00
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About NNE NANO NUCLEAR ENERGY INC
Nano Nuclear Energy Inc is an early-stage nuclear energy company developing smaller, cheaper, and safer portable clean energy solutions. It is focused on four business lines as part of development-Micro Nuclear Reactor Business is developing the next-generation nuclear microreactors, in particular ZEUS, a solid core battery reactor, and ODIN, a low-pressure salt coolant reactor; Fuel Processing Business; Fuel Fabrication Business; Fuel Transportation Business, and Nuclear Consultation Services.